GSE207582 4 V 3 TESTOSTERONE MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207582 4 V 3 TESTOSTERONE MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207582 4 V 3 TESTOSTERONE MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207582 4 V 3 TESTOSTERONE MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207582 4 V 3 TESTOSTERONE MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

DExD-box helicase 52

Gene

RAD52 motif containing 1

Gene

Ras association domain family member 9

Gene

malic enzyme 3

Gene

DNA polymerase delta 3, accessory subunit

Gene

transmembrane protein 98

Gene

PDZ domain containing 4

Gene

WD repeat containing planar cell polarity effector

Gene

SFT2 domain containing 2

  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    DExD-box helicase 52


  • Gene

    RAD52 motif containing 1


  • Gene

    Ras association domain family member 9


  • Gene

    malic enzyme 3


  • Gene

    DNA polymerase delta 3, accessory subunit


  • Gene

    transmembrane protein 98


  • Gene

    PDZ domain containing 4


  • Gene

    WD repeat containing planar cell polarity effector


  • Gene

    SFT2 domain containing 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.